1. Home
  2. UPBD vs TSHA Comparison

UPBD vs TSHA Comparison

Compare UPBD & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upbound Group Inc.

UPBD

Upbound Group Inc.

N/A

Current Price

$17.94

Market Cap

1.2B

ML Signal

N/A

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

N/A

Current Price

$4.62

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UPBD
TSHA
Founded
1986
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
UPBD
TSHA
Price
$17.94
$4.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$32.25
$10.56
AVG Volume (30 Days)
771.8K
2.1M
Earning Date
05-22-2026
01-01-0001
Dividend Yield
8.52%
N/A
EPS Growth
N/A
62.50
EPS
1.25
N/A
Revenue
$4,695,061,000.00
$8,333,000.00
Revenue This Year
$6.30
N/A
Revenue Next Year
$6.67
N/A
P/E Ratio
$14.64
N/A
Revenue Growth
8.67
N/A
52 Week Low
$15.82
$1.13
52 Week High
$28.03
$6.02

Technical Indicators

Market Signals
Indicator
UPBD
TSHA
Relative Strength Index (RSI) 32.17 47.58
Support Level $17.18 $4.41
Resistance Level $19.91 $5.16
Average True Range (ATR) 0.88 0.20
MACD -0.44 0.00
Stochastic Oscillator 5.42 35.71

Price Performance

Historical Comparison
UPBD
TSHA

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: